Share Price:

APNASPENAspen Pharmacare Hldgs170730 (0.00%)

Aspen is in a closed period from 1st July 2024 until the publication of the FY2024 results on the JSE SENS platform to be released on the 3rd September 2024.

Corporate Governance

The Board is accountable to shareholders and other stakeholders and is ultimately responsible for the implementation of sound corporate governance practices throughout the Group. Aspen’s Board of Directors is committed to ensuring that the Group adheres to high standards of corporate governance in the conduct of its business.

In an environment of increasing regulatory pressure, the Board is ever mindful of the need to maintain an appropriate balance between the governance expectations of investors, regulators, government and other stakeholders, and the market demands that the Group delivers competitive financial returns to its shareholders.

Governance in the Group extends beyond mere legislative and regulatory compliance and management strives to entrench an enterprise-wide culture of good governance aimed at ensuring that decisions are taken in a transparent manner, within an ethical framework that promotes the responsible consideration of all stakeholders, while also holding decision makers appropriately accountable.

In line with the philosophy that good corporate governance is an evolving discipline, governance structures, practices and processes are actively monitored and revised from time to time to reflect best practice.

home-page-heritage-sidebar-back-img

Board & Committee Overview
& Constituting Documents

Board

Audit & Risk Committee

Social & Ethics Committee

Remuneration & Nomination Committee

Integrated Reporting

Integrated Reporting Suite

Supplementary Documents

Integrated Reporting Suite

 

Supplementary Documents

Integrated Reporting Suite

 

Supplementary Documents

Integrated Reporting Suite

 

Supplementary Documents

Integrated Reporting Suite

 

Supplementary Documents

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.